Integrated Biosciences and Illumina Ventures Labs Collaborate on Novel Therapeutics Targeting the Transcriptome
BioPharm International The partnership will create therapeutic assets and new discovery platforms and potentially reshape drug discovery. Integrated Biosciences, a biotechnology company that uses synthetic biology and machine learning to develop next-generation therapeutics for age-related diseases, announced on May 28, 2024, that it is collaborating with Illumina Ventures Labs to create novel therapeutics targeting the […]
read more
Navigating Robotic Process Automation, ICH E6(R3) Changes, and Outsourcing in Clinical Trials
Applied Clinical Trials Online With ambitious goals to accelerate clinical trials, increase efficiency, and lower costs, many leading life sciences companies are prioritizing transformation initiatives. Still, challenges persist with managing risk-based approaches, meeting new and changing regulatory requirements, and improving the relationship between sponsors and sites. Advancing trial master file (TMF) processes can help move […]
read more
A flexible solution for eTMF implementation in clinical research
May 14, 2024 – 1:15 PM to 2:00 PM (CEST) Join us for a comprehensive exploration of eTMF, where seasoned experts will discuss its significance, advantages, implementation challenges, regulatory compliance, and future trends. Our esteemed panel will share practical strategies and innovations to streamline eTMF utilisation in clinical trials. Our webinar will focus on an […]
read more
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Med City News Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions. Intellectual property can be a thorny issue in health tech and medtech. The intersection of healthcare data and AI is setting up […]
read more